Home › NuPathe shares soar on news of competing bid
 

Keywords :   


NuPathe shares soar on news of competing bid

2014-01-09 02:36:00| Biotech - Topix.net

NuPathe said in a Securities and Exchange Commission filing that Israel's Teva Pharmaceutical Industries Ltd. wants to buy the company for $3.65 in cash for each NuPathe share, plus up to $3.15 per share in payments if NuPathe's migraine treatment patch Zecuity reaches certain sales milestones.

Tags: news bid shares competing

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.11 115
15.11ZIPP SERVICE COURSE SL 27.2-330mm
15.11/
15.11...
15.114PK super &
15.11PIRELLIP ZERO RACE TLR 700×26c
15.11Nalini M
15.11x92
More »